Yubo International Biotech Limited

Simbol: YBGJ

PNK

0.325

USD

Tržna cena danes

  • -175.4014

    Razmerje P/E

  • -1.8389

    Razmerje PEG

  • 38.94M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Yubo International Biotech Limited (YBGJ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Yubo International Biotech Limited (YBGJ). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Yubo International Biotech Limited, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

0001.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.8

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

00.30.60.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

00.30.20.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

00.40.30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

00.81.11.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.3
0.8

balance-sheet.row.property-plant-equipment-net

01.43.30.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

00.100.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

00.100.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

00.10.20.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

01.63.50.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

02.34.62.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.3
0.8

balance-sheet.row.account-payables

00.50.30.1
0.3
0.3
0.3
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.3
0.4
0.4

balance-sheet.row.short-term-debt

00.40.80.3
1.3
1.2
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.2
0.1
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

00.41.90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01.11.30.1
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3

balance-sheet.row.total-non-current-liabilities

00.41.90
1.6
1.5
1.3
1.2
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.3
0.4
0

balance-sheet.row.other-liabilities

0000
-1.6
-1.5
-1.3
-1.2
-1.1
-1
-0.9
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.3
-0.4
0

balance-sheet.row.capital-lease-obligations

00.82.70.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

02.94.71.3
1.7
1.5
1.4
1.3
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.3
0.3
0.5
0.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.10.10.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.1
0.1

balance-sheet.row.retained-earnings

0-3.7-2.5-0.9
-29
-28.8
-28.7
-28.4
-28.3
-28.2
-28.1
-28
-27.9
-27.8
-27.7
-27.6
-27.5
-27.4
-27.3
-27.2
-27

balance-sheet.row.accumulated-other-comprehensive-income-loss

00.10.10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

02.92.12
27.3
27.3
27.3
27.2
27.2
27.2
27.2
27.2
27.2
27.2
27.2
27.2
27.2
27.1
26.9
26.9
26.9

balance-sheet.row.total-stockholders-equity

0-0.6-0.11.2
-1.7
-1.5
-1.4
-1.3
-1.1
-1
-0.9
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.3
-0.2
0

balance-sheet.row.total-liabilities-and-stockholders-equity

02.34.62.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.3
0.8

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

00.82.70.3
1.3
1.2
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.2
0.1
0
0
0
0
0

balance-sheet.row.net-debt

00.82.7-1.1
1.3
1.1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.2
0.1
0
0
0
-0.3
-0.8

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Yubo International Biotech Limited opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

cash-flows.row.net-income

0-1.2-1.5-0.7
-0.1
-0.1
-0.2
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-101
-0.2
-3

cash-flows.row.depreciation-and-amortization

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

01.20.50.8
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0.1
-0.1
-0.2
0.1

cash-flows.row.account-receivables

00.1-0.20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-0.2-0.1-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

00.30.20.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

010.60.8
-0.3
-0.2
-0.3
-0.2
-0.2
-0.2
-0.2
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0.1
-0.1
-0.2
0.1

cash-flows.row.other-non-cash-items

0000
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.1
0.2
0.1
0.2
0.1
0.2
-0.1
100.9
-0.1
0.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-0.6-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.1

cash-flows.row.net-cash-used-for-investing-activites

00-0.6-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.1

cash-flows.row.debt-repayment

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0000.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

000.10.6
0
0.1
0
0.1
0.1
0
0
0
0.1
0.1
0
0
0
-0.1
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

000.11.4
0
0.1
0
0.1
0.1
0
0
0
0.1
0.1
0
0
0
0.1
0
0
0

cash-flows.row.effect-of-forex-changes-on-cash

000.10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

00-1.41.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.2
-0.5
-2.3

cash-flows.row.cash-at-end-of-period

0001.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.8

cash-flows.row.cash-at-beginning-of-period

001.40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.8
3.1

cash-flows.row.operating-cash-flow

00.1-10.1
0
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
-0.1
-0.1
-0.2
-0.5
-2.3

cash-flows.row.capital-expenditure

00-0.6-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.free-cash-flow

00-1.60
0
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
-0.1
-0.1
-0.2
-0.5
-2.3

Vrstica izkaza poslovnega izida

Prihodki Yubo International Biotech Limited so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja YBGJ znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

income-statement-row.row.total-revenue

00.11.21.4
0
0
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

00.10.40.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

00.10.81.2
0
0
0
0
0
0.1
0.1
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.20.90.8
-0.1
-0.1
0
0
-0.1
-0.1
-0.1
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-101
-0.3
-4

income-statement-row.row.operating-expenses

01.32.42
0
-0.1
0.1
0.1
-0.1
-0.1
-0.1
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-101
-0.2
-3

income-statement-row.row.cost-and-expenses

01.32.82.1
0
0.1
0.1
0.1
0.1
0.1
0.1
0
0.1
0.1
0.1
0.1
0.1
0.1
102
0.2
3.1

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

00427-0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0000
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0.1
0
0.1
71
0.2
-0.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.20.90.8
-0.1
-0.1
0
0
-0.1
-0.1
-0.1
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-101
-0.3
-4

income-statement-row.row.total-operating-expenses

0000
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0.1
0
0.1
71
0.2
-0.2

income-statement-row.row.interest-expense

00427-0.1
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-1.2-1.5-0.7
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-101
-0.2
-3

income-statement-row.row.income-before-tax

0-1.2-1.5-0.7
-0.1
-0.1
-0.2
-0.1
-0.1
-0.1
-0.1
0
0
0
0
0
0
0
-30
0
-3.2

income-statement-row.row.income-tax-expense

0000
0
0
0
0
0
0
0
0.1
0.1
0.1
0.1
0
0
0.1
71
0.2
-0.2

income-statement-row.row.net-income

0-1.2-1.5-0.7
-0.1
-0.1
-0.2
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
0
-0.1
-0.1
-101
-0.2
-3

Pogosto zastavljeno vprašanje

Kaj je Yubo International Biotech Limited (YBGJ) skupna sredstva?

Yubo International Biotech Limited (YBGJ) skupna sredstva so 2348551.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.390.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.002.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -2.586.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -2.620.

Kaj je Yubo International Biotech Limited (YBGJ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -1204765.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 790499.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 1257875.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.